Skip to NavigationSkip to content

Samsung Biologics names John Rim as CEO and President

Published on: 17/12/20

Samsung Biologics has appointed John Rim as the company’s President and CEO. The appointment was made effective immediately and formalised via the company's board of directors meeting yesterday.

Before his appointment as CEO, Rim was Samsung Biologics’ Executive Vice President, and was a key senior leadership contributor in driving the company's success through a strong focus on client satisfaction and global business acumen. He was also instrumental in the rapid expansion of the company’s manufacturing portfolio and the continuous operational excellence in Plant 3, the world's largest manufacturing capacity at a single site. As CEO, Rim will continue to serve on the company's board as an inside director, offering his in-depth industry experience and global background.

With over 30 years’ experience in the biopharmaceutical industry, Rim began his career as a management consultant with Booz, Allen & Hamilton, consulting to pharmaceutical companies in the US and Europe. He has also held numerous senior leadership roles with Astellas Pharmaceuticals, and, before joining Samsung Biologics in 2018, worked for Genentech/Roche in a variety of senior global leadership roles in Technical Operations, Product Development, and Research and Development in the US and Europe.

Rim himself said: “I am deeply grateful and excited by the opportunity to lead Samsung Biologics into the next decade. This is an extraordinary company, unparalleled in its phenomenal growth and dedication to client satisfaction, made possible by the company's unrelenting vision and passion, and business execution by great people whom I will have the privilege to lead as CEO.”

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches